G1 Therapeutics
About:
G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology.
Website: http://www.g1therapeutics.com
Twitter/X: G1Therapeutics
Top Investors: Hercules Capital, RA Capital Management, Cormorant Asset Management, Franklin Templeton, Lumira Ventures
Description:
G1 Therapeutics, Inc. is a commercial-stage oncology firm focused on the research and marketing of next-generation anticancer treatments.
Total Funding Amount:
$697M
Estimated Revenue Range:
$50M to $100M
Headquarters Location:
Durham, North Carolina, United States
Founded Date:
2008-01-01
Contact Email:
info(AT)g1therapeutics.com
Founders:
Kwok-Kin Wong, Norman Sharpless
Number of Employees:
51-100
Last Funding Date:
2022-11-17
IPO Status:
Public
© 2025 bioDAO.ai